US Stock MarketDetailed Quotes

CBBT Cerebain Biotech Corp

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Nov 26 09:30 ET
0Market Cap0.00P/E (TTM)

Cerebain Biotech Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2019
(Q2)Dec 31, 2018
(Q1)Sep 30, 2018
(FY)Jun 30, 2018
(Q4)Jun 30, 2018
(Q3)Mar 31, 2018
(Q2)Dec 31, 2017
(Q1)Sep 30, 2017
(FY)Jun 30, 2017
(Q4)Jun 30, 2017
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
55.49%-143.59K
53.73%-91.03K
38.91%-100.95K
-12.80%-750.01K
70.12%-65.48K
-322.59K
-196.71K
-165.24K
-664.9K
-219.17K
Net income from continuing operations
40.39%-390.21K
89.13%-371.14K
-24.52%-537.3K
69.28%-4.92M
25.46%-419.73K
---654.6K
---3.41M
---431.48K
---16.01M
---563.08K
Operating gains losses
-58.57%67.8K
-102.19%-67.17K
382.57%144.77K
-77.89%3.05M
---219.88K
--163.65K
--3.07M
--30K
--13.78M
--0
Other non cash items
-132.83%-8.35K
8,080.16%136.45K
5,368.65%91.22K
595.98%302.62K
--273.86K
--25.42K
--1.67K
--1.67K
--43.48K
----
Change In working capital
771.68%150.39K
108.13%187.09K
68.70%162.33K
18.01%479.17K
694.86%275.8K
--17.25K
--89.89K
--96.22K
--406.05K
--34.7K
-Change in prepaid assets
121.14%12.39K
-65.88%12.72K
---2.5K
195.54%38.22K
834.45%59.54K
---58.59K
--37.27K
--0
---40K
--6.37K
-Change in payables and accrued expense
81.95%138K
231.36%174.37K
71.30%164.83K
-1.14%440.95K
663.46%216.26K
--75.85K
--52.62K
--96.22K
--446.05K
--28.33K
Cash from discontinued investing activities
Operating cash flow
55.49%-143.59K
53.73%-91.03K
38.91%-100.95K
-12.80%-750.01K
70.12%-65.48K
---322.59K
---196.71K
---165.24K
---664.9K
---219.17K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-58.36%145K
-65.00%70K
-51.61%75K
22.45%803.25K
-56.52%100K
348.25K
200K
155K
656K
230K
Net issuance payments of debt
-39.14%145K
-30.00%70K
0.00%75K
-1.30%513.25K
-42.86%100K
--238.25K
--100K
--75K
--520K
--175K
Net common stock issuance
----
----
----
190.00%290K
--0
--110K
--100K
--80K
--100K
--50K
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
--36K
--5K
Cash from discontinued financing activities
Financing cash flow
-58.36%145K
-65.00%70K
-51.61%75K
22.45%803.25K
-56.52%100K
--348.25K
--200K
--155K
--656K
--230K
Net cash flow
Beginning cash position
300.16%17.61K
3,380.45%38.63K
469.26%64.58K
-43.96%11.35K
5,715.09%30.06K
--4.4K
--1.11K
--11.35K
--20.25K
--517
Current changes in cash
-94.49%1.42K
-739.09%-21.03K
-153.54%-25.95K
698.18%53.24K
218.79%34.52K
--25.66K
--3.29K
---10.24K
---8.9K
--10.83K
End cash Position
-36.73%19.02K
300.16%17.61K
3,380.45%38.63K
469.26%64.58K
469.26%64.58K
--30.06K
--4.4K
--1.11K
--11.35K
--11.35K
Free cash flow
55.49%-143.59K
53.73%-91.03K
38.91%-100.95K
-12.80%-750.01K
70.12%-65.48K
---322.59K
---196.71K
---165.24K
---664.9K
---219.17K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Mar 31, 2019(Q2)Dec 31, 2018(Q1)Sep 30, 2018(FY)Jun 30, 2018(Q4)Jun 30, 2018(Q3)Mar 31, 2018(Q2)Dec 31, 2017(Q1)Sep 30, 2017(FY)Jun 30, 2017(Q4)Jun 30, 2017
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 55.49%-143.59K53.73%-91.03K38.91%-100.95K-12.80%-750.01K70.12%-65.48K-322.59K-196.71K-165.24K-664.9K-219.17K
Net income from continuing operations 40.39%-390.21K89.13%-371.14K-24.52%-537.3K69.28%-4.92M25.46%-419.73K---654.6K---3.41M---431.48K---16.01M---563.08K
Operating gains losses -58.57%67.8K-102.19%-67.17K382.57%144.77K-77.89%3.05M---219.88K--163.65K--3.07M--30K--13.78M--0
Other non cash items -132.83%-8.35K8,080.16%136.45K5,368.65%91.22K595.98%302.62K--273.86K--25.42K--1.67K--1.67K--43.48K----
Change In working capital 771.68%150.39K108.13%187.09K68.70%162.33K18.01%479.17K694.86%275.8K--17.25K--89.89K--96.22K--406.05K--34.7K
-Change in prepaid assets 121.14%12.39K-65.88%12.72K---2.5K195.54%38.22K834.45%59.54K---58.59K--37.27K--0---40K--6.37K
-Change in payables and accrued expense 81.95%138K231.36%174.37K71.30%164.83K-1.14%440.95K663.46%216.26K--75.85K--52.62K--96.22K--446.05K--28.33K
Cash from discontinued investing activities
Operating cash flow 55.49%-143.59K53.73%-91.03K38.91%-100.95K-12.80%-750.01K70.12%-65.48K---322.59K---196.71K---165.24K---664.9K---219.17K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -58.36%145K-65.00%70K-51.61%75K22.45%803.25K-56.52%100K348.25K200K155K656K230K
Net issuance payments of debt -39.14%145K-30.00%70K0.00%75K-1.30%513.25K-42.86%100K--238.25K--100K--75K--520K--175K
Net common stock issuance ------------190.00%290K--0--110K--100K--80K--100K--50K
Proceeds from stock option exercised by employees --------------0------------------36K--5K
Cash from discontinued financing activities
Financing cash flow -58.36%145K-65.00%70K-51.61%75K22.45%803.25K-56.52%100K--348.25K--200K--155K--656K--230K
Net cash flow
Beginning cash position 300.16%17.61K3,380.45%38.63K469.26%64.58K-43.96%11.35K5,715.09%30.06K--4.4K--1.11K--11.35K--20.25K--517
Current changes in cash -94.49%1.42K-739.09%-21.03K-153.54%-25.95K698.18%53.24K218.79%34.52K--25.66K--3.29K---10.24K---8.9K--10.83K
End cash Position -36.73%19.02K300.16%17.61K3,380.45%38.63K469.26%64.58K469.26%64.58K--30.06K--4.4K--1.11K--11.35K--11.35K
Free cash flow 55.49%-143.59K53.73%-91.03K38.91%-100.95K-12.80%-750.01K70.12%-65.48K---322.59K---196.71K---165.24K---664.9K---219.17K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data